Scandinavian Journal of Rheumatology最新文献

筛选
英文 中文
Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain. 抗瓜氨酸蛋白抗体阳性肌肉骨骼疼痛患者血清蛋白电泳成分对关节炎发展的预后价值。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2024-01-12 DOI: 10.1080/03009742.2023.2294578
S Åhammar, K Martinsson, M Ziegelasch, A Kastbom
{"title":"Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain.","authors":"S Åhammar, K Martinsson, M Ziegelasch, A Kastbom","doi":"10.1080/03009742.2023.2294578","DOIUrl":"10.1080/03009742.2023.2294578","url":null,"abstract":"<p><strong>Objective: </strong>Predictors of arthritis development in patients with anti-citrullinated protein antibodies (ACPAs) and musculoskeletal symptoms are needed for risk stratification and to improve clinical outcomes. The aim of this study was to assess the relationship between serum protein electrophoresis (SPE) constituents and the development of clinical arthritis in ACPA-positive patients with musculoskeletal pain.</p><p><strong>Method: </strong>We prospectively followed 82 ACPA-positive patients with musculoskeletal pain but no baseline arthritis during a median of 72 months (interquartile range 57-81 months). The primary outcome was arthritis development, as judged by clinical examination. SPE constituents were evaluated in baseline sera by immunoturbidimetric methods. Serum levels of the analysed proteins (albumin, orosomucoid, α<sub>1</sub>-anti-trypsin, haptoglobin, and immunoglobulins IgA, IgG, and IgM) were related to arthritis development by Cox regression analyses.</p><p><strong>Results: </strong>During the follow-up period, 39/82 patients (48%) progressed to arthritis. Median baseline levels of orosomucoid and α<sub>1</sub>-anti-trypsin were higher in patients who developed arthritis than in those who did not (p = 0.04), while median albumin levels were significantly lower (p = 0.03). Immunoglobulin levels did not differ between the groups. Univariable analysis demonstrated a significantly increased risk of arthritis with elevated baseline haptoglobin [hazard ratio (HR) 2.53, 95% confidence interval (CI) 1.32-4.85, p = 0.005] and orosomucoid levels (HR 2.63, 95% CI 1.09-6.31, p = 0.03). However, neither remained significant in multivariable analysis adjusting for elevated C-reactive protein (CRP) levels.</p><p><strong>Conclusion: </strong>SPE does not add prognostic value for arthritis development in ACPA-positive patients with musculoskeletal pain.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"118-122"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor. 一名接受肿瘤坏死因子-α抑制剂治疗的银屑病关节炎患者患上了皮肤利什曼病。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2024-01-26 DOI: 10.1080/03009742.2023.2295627
N V Morsing, C M Andreasen, T A Rasmussen, L T Moll
{"title":"Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor.","authors":"N V Morsing, C M Andreasen, T A Rasmussen, L T Moll","doi":"10.1080/03009742.2023.2295627","DOIUrl":"10.1080/03009742.2023.2295627","url":null,"abstract":"","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"158-159"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139564142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call for Papers: Special Issue on Interstitial Lung Disease in the Setting of Rheumatic Disorders. 征稿启事:风湿性疾病引起的间质性肺病特刊。
IF 2.1 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2024-02-26 DOI: 10.1080/03009742.2024.2310462
{"title":"Call for Papers: Special Issue on Interstitial Lung Disease in the Setting of Rheumatic Disorders.","authors":"","doi":"10.1080/03009742.2024.2310462","DOIUrl":"https://doi.org/10.1080/03009742.2024.2310462","url":null,"abstract":"","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":"53 2","pages":"160"},"PeriodicalIF":2.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment. 巴比替尼治疗加重类风湿关节炎相关间质性肺疾病的疗效
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2023-11-30 DOI: 10.1080/03009742.2023.2274707
T Komai, T Sawada, H Tsuchiya, H Harada, H Shoda, K Fujio
{"title":"Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.","authors":"T Komai, T Sawada, H Tsuchiya, H Harada, H Shoda, K Fujio","doi":"10.1080/03009742.2023.2274707","DOIUrl":"10.1080/03009742.2023.2274707","url":null,"abstract":"","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"146-148"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138462456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ASAS Health Index and Environmental Factors Item Set: validity and reliability of the Swedish translations in Swedish patients with ankylosing spondylitis. ASAS健康指数和环境因素项目集:瑞典强直性脊柱炎患者瑞典语翻译的有效性和可靠性。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2023-10-31 DOI: 10.1080/03009742.2023.2266903
C Feldthusen, M Hallström, A d'Elia, A Deminger, U Kiltz, H Forsblad-d'Elia
{"title":"The ASAS Health Index and Environmental Factors Item Set: validity and reliability of the Swedish translations in Swedish patients with ankylosing spondylitis.","authors":"C Feldthusen, M Hallström, A d'Elia, A Deminger, U Kiltz, H Forsblad-d'Elia","doi":"10.1080/03009742.2023.2266903","DOIUrl":"10.1080/03009742.2023.2266903","url":null,"abstract":"<p><strong>Objectives: </strong>To translate the Assessment of SpondyloArthritis international Society (ASAS) Health Index (HI) Environmental Factors Item Set (EFIS) into Swedish and culturally adapt it for a Swedish context, and to assess the construct validity of the Swedish version of the ASAS HI and test-retest reliability in ASAS HI and EFIS in Swedish patients with ankylosing spondylitis (AS).</p><p><strong>Method: </strong>Translation and cross-cultural adaptation of the EFIS were carried out according to a forward-backward procedure consisting of five steps. The construct validity of the ASAS HI was tested using Spearman correlation with standard health outcomes for axial spondyloarthritis (axSpA). Reliability was analysed by internal consistency with the Cronbach's alpha coefficient for ASAS HI, and test-retest reliability with intraclass correlation coefficients (ICCs) for ASAS HI and kappa agreement for the individual items of EFIS.</p><p><strong>Results: </strong>The translation of EFIS showed acceptable face and content validity. ASAS HI showed an acceptable internal consistency (Cronbach's alpha 0.79), and excellent test-retest reliability (ICC 0.87). Test-retest reliability for EFIS showed varied results, with kappa agreement for the individual items ranging from poor (-0.027) to good (0.80).</p><p><strong>Conclusions: </strong>The Swedish version of ASAS HI proved to be valid and reliable and is recommended for assessing the impact of AS on global functioning and health. A Swedish version of EFIS has been produced and uploaded on the ASAS website. The EFIS proved to have acceptable face and content validity, and may contribute to the contextual interpretation of the ASAS HI.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"104-111"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71413814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Danish translation and cultural adaptation of the Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4) scale. 银屑病关节炎 UnclutteRed 筛选评估(PURE-4)量表的丹麦语翻译和文化适应性调整。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2024-01-08 DOI: 10.1080/03009742.2023.2295723
Cdb Elgaard, T B Laurberg, R D Østgård, M Pilegaard, P Steffensen, M Flanagan, A Fage-Butler, A G Loft, K F Hjuler
{"title":"Danish translation and cultural adaptation of the Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4) scale.","authors":"Cdb Elgaard, T B Laurberg, R D Østgård, M Pilegaard, P Steffensen, M Flanagan, A Fage-Butler, A G Loft, K F Hjuler","doi":"10.1080/03009742.2023.2295723","DOIUrl":"10.1080/03009742.2023.2295723","url":null,"abstract":"<p><strong>Objectives: </strong>Screening tools are needed to help to identify psoriatic arthritis in patients with psoriasis. The Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4) questionnaire was developed for this purpose and has been shown to perform very well. The aim of this study was to translate and culturally adapt the PURE-4 scale into the Danish language.</p><p><strong>Method: </strong>The translational process followed the guidelines provided by the Mapi Research Trust, which include the following steps: forward translation, backward translation, cognitive interviews, and proofreading. Following the guidelines helps to maintain the content validity of the questionnaire and secures a translation that is both literally and culturally appropriate for the target population.</p><p><strong>Results: </strong>All four items were modified throughout the translation process, involving mainly minor changes such as the addition of more colloquial words in the Danish version. The new Danish version of PURE-4 was reviewed and approved by the original developers.</p><p><strong>Conclusions: </strong>A Danish version of the PURE-4 questionnaire was produced. The translation and cultural adaptation of PURE-4 constitute the first step in the validation of the questionnaire in Danish patients with psoriasis.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"140-145"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis. 用于检测类风湿性关节炎疾病活动的光学光谱透射成像临床评估。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2023-03-28 DOI: 10.1080/03009742.2023.2177382
A B Blanken, M Korteweg, L van Boheemen, R F van Vollenhoven, M T Nurmohamed, C J van der Laken
{"title":"Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis.","authors":"A B Blanken, M Korteweg, L van Boheemen, R F van Vollenhoven, M T Nurmohamed, C J van der Laken","doi":"10.1080/03009742.2023.2177382","DOIUrl":"10.1080/03009742.2023.2177382","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the performance and factors of influence of optical spectral transmission (OST) imaging as a new technique for measuring joint inflammation in rheumatoid arthritis (RA).</p><p><strong>Method: </strong>OST was performed in 24 RA patients and 37 controls. Mann-Whitney U-test was used to assess differences in OST score between RA patients and controls. Receiver operating characteristics (ROC), linear regression and generalized estimating equations analysis were used to assess the discriminative capability of OST and the association of OST score with clinical disease parameters, ultrasound, radiographic features and cardiovascular risk parameters.</p><p><strong>Results: </strong>Median OST score was higher in RA patients than in controls [16.9 (interquartile range 12.77-19.7) vs 12.11 (10.32-14.93)]. At patient level, OST score was moderately associated with ultrasound [beta 0.38 (95% CI 0.16-0.60), p = 0.001] and clinical disease activity [28-joint Disease Activity Score-C-reactive protein beta 0.30 (95% CI 0.04- 0.57), p = 0.024] in RA patients. In controls, male sex, high body mass index, and hypertension were associated with higher OST scores, while these associations were absent in RA. At joint level, the area under the ROC curve for OST score, with ultrasound or clinical swelling as reference, ranged from 0.63 to 0.70. Joint-space narrowing and malalignment were associated with higher OST joint scores, and subchondral sclerosis with lower scores.</p><p><strong>Conclusion: </strong>OST provides an objective measure of synovitis and correlates moderately with other examined disease activity assessment tools. Clinical patient characteristics must be considered when interpreting the results.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"85-93"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9562122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis. 治疗过程中的转折:一名患有 COVID-19 类风湿性关节炎的患者因托西珠单抗引发肠穿孔。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-03-01 Epub Date: 2024-01-10 DOI: 10.1080/03009742.2023.2294580
W-H Yoo, G W Ha, K M Kim, Y Choi
{"title":"When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.","authors":"W-H Yoo, G W Ha, K M Kim, Y Choi","doi":"10.1080/03009742.2023.2294580","DOIUrl":"10.1080/03009742.2023.2294580","url":null,"abstract":"","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"155-157"},"PeriodicalIF":2.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139404230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic miliary gout complicated by chronic renal failure: a case report 慢性肾功能衰竭并发慢性淤积性痛风:一份病例报告
IF 2.1 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-02-26 DOI: 10.1080/03009742.2024.2315706
X Zhang, Z Li, Y Zhou, L Huang
{"title":"Chronic miliary gout complicated by chronic renal failure: a case report","authors":"X Zhang, Z Li, Y Zhou, L Huang","doi":"10.1080/03009742.2024.2315706","DOIUrl":"https://doi.org/10.1080/03009742.2024.2315706","url":null,"abstract":"Published in Scandinavian Journal of Rheumatology (Ahead of Print, 2024)","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":"256 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139969819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A trial-based economic evaluation of the CaFaSpA referral strategy for axial spondyloarthritis. 基于试验的轴性脊柱关节炎 CaFaSpA 转诊策略经济评估。
IF 2.2 4区 医学
Scandinavian Journal of Rheumatology Pub Date : 2024-01-01 Epub Date: 2023-08-31 DOI: 10.1080/03009742.2023.2243081
M Jamal, T M Kuijper, Jmw Hazes, D Lopes Barreto, Aeam Weel
{"title":"A trial-based economic evaluation of the CaFaSpA referral strategy for axial spondyloarthritis.","authors":"M Jamal, T M Kuijper, Jmw Hazes, D Lopes Barreto, Aeam Weel","doi":"10.1080/03009742.2023.2243081","DOIUrl":"10.1080/03009742.2023.2243081","url":null,"abstract":"<p><strong>Objective: </strong>To assess the cost-utility from healthcare and societal perspectives of the digital CaFaSpA referral strategy (CS) for axial spondyloarthritis (axSpA) in primary care patients with chronic low back pain (CLBP).</p><p><strong>Method: </strong>A cluster randomized controlled trial was performed in the Netherlands. General practice units were randomized into CS or usual care (UC). Economic evaluation was performed from the healthcare and societal perspectives within a 12-month time horizon. Outcome measures encompassed disability [Roland-Morris Disability Questionnaire (RMDQ)] and health-related quality of life (EQ-5D-3L). Direct medical (iMTA Medical Consumption Questionnaire) and indirect costs (iMTA Productivity Cost Questionnaire), including productivity loss, were evaluated. Incremental cost-utility ratios (ICURs) were calculated.</p><p><strong>Results: </strong>The study included 90 GP clusters with 563 patients (CS: n = 260; UC: n = 303) (mean ± sd age 36.3 ± 7.5 years; 66% female). After 12 months, no minimal important differences in outcomes were observed for RMDQ (-0.21, 95%CI -1.52 to 1.13) or EQ-5D (-0.02, 95%CI -0.08 to 0.05). However, total costs were significantly lower in the CS group owing to lower productivity loss costs. The ICUR for RMDQ was €18,059 per point decrease and €220,457 per quality-adjusted life year increase.</p><p><strong>Conclusions: </strong>Digital referral did not decrease the overall healthcare status of patients after 1 year of follow-up and appears to be more cost-effective than UC. Therefore, CS can be used as an appropriate primary care referral model for CLBP patients at risk for axSpA. This will accelerate timely provision of care by the right caregiver.</p>","PeriodicalId":21424,"journal":{"name":"Scandinavian Journal of Rheumatology","volume":" ","pages":"1-9"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10121333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信